1. Home
  2. CIEN vs RGEN Comparison

CIEN vs RGEN Comparison

Compare CIEN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIEN
  • RGEN
  • Stock Information
  • Founded
  • CIEN 1992
  • RGEN 1981
  • Country
  • CIEN United States
  • RGEN United States
  • Employees
  • CIEN N/A
  • RGEN N/A
  • Industry
  • CIEN Telecommunications Equipment
  • RGEN Medical/Dental Instruments
  • Sector
  • CIEN Utilities
  • RGEN Health Care
  • Exchange
  • CIEN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CIEN 10.2B
  • RGEN 8.0B
  • IPO Year
  • CIEN 1997
  • RGEN N/A
  • Fundamental
  • Price
  • CIEN $81.00
  • RGEN $121.80
  • Analyst Decision
  • CIEN Buy
  • RGEN Buy
  • Analyst Count
  • CIEN 14
  • RGEN 11
  • Target Price
  • CIEN $82.62
  • RGEN $169.33
  • AVG Volume (30 Days)
  • CIEN 2.2M
  • RGEN 691.4K
  • Earning Date
  • CIEN 09-03-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • CIEN N/A
  • RGEN N/A
  • EPS Growth
  • CIEN N/A
  • RGEN N/A
  • EPS
  • CIEN 0.73
  • RGEN N/A
  • Revenue
  • CIEN $4,264,558,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CIEN $16.34
  • RGEN $13.93
  • Revenue Next Year
  • CIEN $9.74
  • RGEN $14.35
  • P/E Ratio
  • CIEN $111.45
  • RGEN N/A
  • Revenue Growth
  • CIEN 2.86
  • RGEN 4.88
  • 52 Week Low
  • CIEN $44.89
  • RGEN $102.97
  • 52 Week High
  • CIEN $101.44
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CIEN 48.91
  • RGEN 49.09
  • Support Level
  • CIEN $77.11
  • RGEN $123.34
  • Resistance Level
  • CIEN $81.84
  • RGEN $135.57
  • Average True Range (ATR)
  • CIEN 2.17
  • RGEN 4.32
  • MACD
  • CIEN -0.21
  • RGEN 0.63
  • Stochastic Oscillator
  • CIEN 41.83
  • RGEN 34.18

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: